Skip to main content

Theravance Biopharma, Inc.

TBPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583107

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Theravance Biopharma, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
+9 vs. Q3 2024
Shares held
44.9M
−877.0K (−1.9%) vs. Q3 2024
Total value
$422.4M
+$53.5M (+14.5%) vs. Q3 2024
New holders
24
43 more added
Sold out
15
33 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 128 institutions
Q1 2021: 107 institutionsQ2 2021: 109 institutionsQ3 2021: 119 institutionsQ4 2021: 116 institutionsQ1 2022: 121 institutionsQ2 2022: 113 institutionsQ3 2022: 123 institutionsQ4 2022: 119 institutionsQ1 2023: 114 institutionsQ2 2023: 119 institutionsQ3 2023: 115 institutionsQ4 2023: 118 institutionsQ1 2024: 121 institutionsQ2 2024: 132 institutionsQ3 2024: 119 institutionsQ4 2024: 128 institutionsQ1 2025: 132 institutionsQ2 2025: 135 institutionsQ3 2025: 161 institutionsQ4 2025: 169 institutionsQ1 2026: 173 institutionsQ2 2026: 179 institutions
Value heldQ4 2024: $422.4M
Q1 2021: $1.09BQ2 2021: $883.1MQ3 2021: $448.8MQ4 2021: $655.6MQ1 2022: $602.5MQ2 2022: $582.0MQ3 2022: $649.8MQ4 2022: $696.1MQ1 2023: $652.6MQ2 2023: $546.3MQ3 2023: $438.5MQ4 2023: $548.7MQ1 2024: $430.6MQ2 2024: $399.5MQ3 2024: $368.9MQ4 2024: $422.4MQ1 2025: $400.9MQ2 2025: $512.2MQ3 2025: $706.3MQ4 2025: $927.2MQ1 2026: $814.2MQ2 2026: $817.5M
Institutions holding TBPH and their total value by quarter
QuarterHoldersValue
Q2 2026179$817.5M
Q1 2026173$814.2M
Q4 2025169$927.2M
Q3 2025161$706.3M
Q2 2025135$512.2M
Q1 2025132$400.9M
Q4 2024128$422.4M
Q3 2024119$368.9M
Q2 2024132$399.5M
Q1 2024121$430.6M
Q4 2023118$548.7M
Q3 2023115$438.5M
Q2 2023119$546.3M
Q1 2023114$652.6M
Q4 2022119$696.1M
Q3 2022123$649.8M
Q2 2022113$582.0M
Q1 2022121$602.5M
Q4 2021116$655.6M
Q3 2021119$448.8M
Q2 2021109$883.1M
Q1 2021107$1.09B

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q3 2024.

Institutions holding TBPH in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Millennium Management LLC192,839$1.81M0.00%+80,140+71.1%Added
Tudor Investment Corp Et Al196,578$1.85M0.02%00.0%Unchanged
Wellington Management Group LLP198,491$1.87M0.00%+7,162+3.7%Added
Macquarie Group Ltd208,783$1.97M0.00%00.0%Unchanged
JPMorgan Chase & Co219,568$2.07M0.00%−47,311−17.7%Reduced
Goldman Sachs Group Inc225,103$2.12M0.00%−64,686−22.3%Reduced
Tang Capital Management LLC262,896$2.47M0.16%00.0%Unchanged
Charles Schwab Investment Management Inc293,936$2.77M0.00%+2,060+0.7%Added
BNP Paribas Arbitrage, SA305,615$2.88M0.00%+1350.0%Added
Citadel Advisors LLC314,622$2.96M0.00%+80,066+34.1%Added
Northern Trust Corp389,980$3.67M0.00%+6,198+1.6%Added
Morgan Stanley392,333$3.69M0.00%−103,480−20.9%Reduced
Jacobs Levy Equity Management, Inc438,463$4.13M0.01%−137,984−23.9%Reduced
Bank of America Corp481,475$4.53M0.00%+12,596+2.7%Added
Nuveen Asset Management, LLC495,727$4.66M0.00%+48,635+10.9%Added
Dimensional Fund Advisors LP553,713$5.21M0.00%+95,304+20.8%Added
D. E. Shaw & Co., Inc.833,943$7.85M0.01%+69,178+9.0%Added
Geode Capital Management, LLC862,802$8.12M0.00%+4,823+0.6%Added
Camber Capital Management LP1,000,000$9.41M0.37%00.0%Unchanged
Oasis Management Co Ltd.1,115,765$10.5M3.50%00.0%Unchanged
State Street Corp1,222,470$11.5M0.00%+30,849+2.6%Added
Park West Asset Management LLC1,792,988$16.9M1.40%−70,000−3.8%Reduced
Vanguard Group Inc2,010,544$18.9M0.00%−41,145−2.0%Reduced
Irenic Capital Management LP2,760,948$26.0M3.96%00.0%Unchanged
BlackRock, Inc.3,712,303$34.9M0.00%−19,002−0.5%Reduced
Newtyn Management, LLC4,757,403$44.8M7.80%+258,337+5.7%Added
Weiss Asset Management LP7,457,060$70.2M1.60%00.0%Unchanged
Madison Avenue Partners, LP9,511,150$89.5M9.48%00.0%Unchanged
Pictet Asset Management Holding SA0$00.00%−684,892−100.0%Sold out
Algert Global LLC0$00.00%−105,609−100.0%Sold out
Royce & Associates LP0$00.00%−59,009−100.0%Sold out
Prudential Financial Inc0$00.00%−57,240−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−38,018−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−34,746−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−31,194−100.0%Sold out
Verition Fund Management LLC0$00.00%−12,642−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−11,093−100.0%Sold out
Quantbot Technologies LP0$00.00%−7,396−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−521−100.0%Sold out
Simplex Trading, LLC0$00.00%−323−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−57−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−5−100.0%Sold out
Covestor Ltd0$00.00%−31−100.0%Sold out